These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28593503)

  • 1. Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma.
    Yeh CC; Goyal A; Shen J; Wu HC; Strauss JA; Wang Q; Gurvich I; Safyan RA; Manji GA; Gamble MV; Siegel AB; Santella RM
    Ann Surg Oncol; 2017 Nov; 24(12):3788-3795. PubMed ID: 28593503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
    Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
    Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma.
    Zhu C; Utsunomiya T; Ikemoto T; Yamada S; Morine Y; Imura S; Arakawa Y; Takasu C; Ishikawa D; Imoto I; Shimada M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S729-35. PubMed ID: 24992910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum folate concentrations at diagnosis are associated with hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort study.
    Fang AP; Liu ZY; Liao GC; Chen PY; Wang XY; Zhang DM; Luo Y; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
    Br J Nutr; 2019 Jun; 121(12):1376-1388. PubMed ID: 30935429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma.
    Ramzy II; Omran DA; Hamad O; Shaker O; Abboud A
    Arab J Gastroenterol; 2011 Sep; 12(3):139-42. PubMed ID: 22055592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma.
    Gao XD; Qu JH; Chang XJ; Lu YY; Bai WL; Wang H; Xu ZX; An LJ; Wang CP; Zeng Z; Yang YP
    Liver Int; 2014 Jan; 34(1):136-46. PubMed ID: 23875825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection.
    Liu ZJ; Huang Y; Wei L; He JY; Liu QY; Yu XQ; Li ZL; Zhang J; Li B; Sun CJ; Liang WB; Sun AM; Qin Y
    Neoplasma; 2017; 64(5):795-802. PubMed ID: 28592132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Sakamaki K; Ohashi Y; Baba H
    Ann Surg; 2013 Mar; 257(3):449-55. PubMed ID: 23023202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.
    Tangkijvanich P; Hourpai N; Rattanatanyong P; Wisedopas N; Mahachai V; Mutirangura A
    Clin Chim Acta; 2007 Apr; 379(1-2):127-33. PubMed ID: 17303099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
    Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
    Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
    Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype.
    Anwar SL; Hasemeier B; Schipper E; Vogel A; Kreipe H; Lehmann U
    PLoS One; 2019; 14(5):e0216374. PubMed ID: 31059558
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort.
    Fang AP; Chen PY; Wang XY; Liu ZY; Zhang DM; Luo Y; Liao GC; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
    Int J Cancer; 2019 Jun; 144(11):2823-2832. PubMed ID: 30426509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma.
    Lee YR; Kim G; Lee HW; Tak WY; Park SY; Jang SY; Kweon YO; Park JG; Han YS; Chun JM; Han JR; Hur K
    Medicine (Baltimore); 2021 Apr; 100(16):e25552. PubMed ID: 33879706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.
    Zhang C; Xu Y; Zhao J; Fan L; Jiang G; Li R; Ling Y; Wu M; Wei L
    Ann Surg Oncol; 2011 Aug; 18(8):2373-80. PubMed ID: 21331808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
    Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
    Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.
    Dong X; He H; Zhang W; Yu D; Wang X; Chen Y
    Diagn Pathol; 2015 Aug; 10():133. PubMed ID: 26238200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Folate and Vitamin B12 Levels in Patients with Hepatocellular Carcinoma.
    Cui LH; Quan ZY; Piao JM; Zhang TT; Jiang MH; Shin MH; Choi JS
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27376276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.